HIV Citation List: October 15 - October 28, 2010

Pubmed citations:

1. Synthesis, antiviral and contraceptive activities of nucleoside-sodium cellulose sulfate acetate and succinate conjugates. Agarwal, H.K., A. Kumar, G.F. Doncel, and K. Parang. Bioorganic & Medicinal Chemistry Letters, 2010. [EPub Ahead of Print]; PMID[20965725].

[Pubmed]. HIV_1015-102810.

2. Structure-Based Design, Synthesis, and Structure-Activity Relationship Studies of HIV-1 Protease Inhibitors Incorporating Phenyloxazolidinones. Ali, A., G.S. Reddy, M.N. Nalam, S.G. Anjum, H. Cao, C.A. Schiffer, and T.M. Rana,. Journal of Medicinal Chemistry, 2010. [Epub Ahead of Print]; PMID[20958050].

[Pubmed]. HIV_1015-102810.

3. Design, Synthesis, and Biological Evaluation of Novel Hybrid Dicaffeoyltartaric/Diketo Acid and Tetrazole-Substituted l-Chicoric Acid Analogue Inhibitors of Human Immunodeficiency Virus Type 1 Integrase. Crosby, D.C., X. Lei, C.G. Gibbs, B.R. McDougall, W.E. Robinson, and M.G. Reinecke. Journal of Medicinal Chemistry, 2010. [EPub Ahead of Print]; PMID[20977258].

[Pubmed]. HIV_1015-102810.

4. Iron Chelators of the DpT and BpT Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets - Iron, CDK2 and CDK9. Debebe, Z., T. Ammosova, D. Breuer, D. Lovejoy, D. Kalinowski, P. Karla, K. Kumar, M. Jerebtsova, P. Ray, F. Kashanchi, V. Gordeuk, D.R. Richardson, and S. Nekhai. Molecular Pharmacology, 2010. [EPub Ahead of Print]; PMID[20956357].

[Pubmed]. HIV_1015-102810.

5. Inhibition of HIV-1 by non-nucleoside reverse transcriptase inhibitors via an induced fit mechanism-Importance of slow dissociation and relaxation rates for antiviral efficacy. Elinder, M., P. Selhorst, G. Vanham, B. Oberg, L. Vrang, and U.H. Danielson. Biochemical Pharmacology, 2010. 80(8): p. 1133-1140; PMID[20599774].

[Pubmed]. HIV_1015-102810.

6. Isolation of a New Trypsin Inhibitor from the Faba bean (Vicia faba cv. Giza 843) with Potential Medicinal Applications. Fang, E.F., A. Abd Elazeem Hassanien, J.H. Wong, C.S. Bah, S.S. Soliman, and T.B. Ng. Protein & Peptide Letters, 2010. [EPub Ahead of Print]; PMID[20955169].

[Pubmed]. HIV_1015-102810.

7. Validated predictive QSAR modeling of N-aryl-oxazolidinone-5-carboxamides for anti-HIV protease activity. Halder, A.K. and T. Jha. Bioorganic & Medicinal Chemistry Letters, 2010. 20(20): p. 6082-6087; PMID[20832304].

[Pubmed]. HIV_1015-102810.

8. Small-molecule inactivation of HIV-1 NCp7 by repetitive intracellular acyl transfer. Jenkins, L.M., D.E. Ott, R. Hayashi, L.V. Coren, D. Wang, Q. Xu, M.L. Schito, J.K. Inman, D.H. Appella, and E. Appella. Nature Chemical Biology, 2010. [EPub Ahead of Print]; PMID[20953192].

[Pubmed]. HIV_1015-102810.

9. Selective killing of human immunodeficiency virus infected cells by non-nucleoside reverse transcriptase inhibitor-induced activation of HIV protease. Jochmans, D., M. Anders, I. Keuleers, L. Smeulders, H.G. Kraeusslich, G. Kraus, and B. Mueller. Retrovirology, 2010. 7(1): p. 89; PMID[20950436].

[Pubmed]. HIV_1015-102810.

10. A Potent Strategy to Inhibit HIV-1 by Binding Both gp120 and gp41. Kagiampakis, I., A. Gharibi, M.K. Mankowski, B.A. Snyder, R.G. Ptak, K. Alatas, and P.J. Liwang. Antimicrobial Agents and Chemotherapy, 2010. [EPub Ahead of Print]; PMID[20956603].

[Pubmed]. HIV_1015-102810.

11. Novel fold and carbohydrate specificity of the potent anti-HIV cyanobacterial lectin from oscillatoria agardhii. Koharudin, L.M., W. Furey, and A.M. Gronenborn. The Journal of Biological Chemistry, 2010. [EPub Ahead of Print]; PMID[20961847].

[Pubmed]. HIV_1015-102810.

12. Tetra-end-linked oligonucleotides forming DNA G-quadruplexes: a new class of aptamers showing anti-HIV activity. Oliviero, G., J. Amato, N. Borbone, S. D'Errico, A. Galeone, L. Mayol, S. Haider, O. Olubiyi, B. Hoorelbeke, J. Balzarini, and G. Piccialli. Chemical Communications (Cambridge), 2010. [EPub Ahead of Print]; PMID[20972507].

[Pubmed]. HIV_1015-102810.

13. Synthesis of Conformationally Locked l-Deoxythreosyl Phosphonate Nucleosides Built on a Bicyclo[3.1.0]hexane Template. Saneyoshi, H., J.R. Deschamps, and V.E. Marquez. Journal of Organic Chemistry, 2010. [EPub Ahead of Print]; PMID[20964394].

[Pubmed]. HIV_1015-102810.

14. Recent advances in anti-HIV natural products. Singh, I.P. and H.S. Bodiwala. Natural Product Reports, 2010. [EPub Ahead of Print]; PMID[20976350].

[Pubmed]. HIV_1015-102810.

15. Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped viruses. St Vincent, M.R., C.C. Colpitts, A.V. Ustinov, M. Muqadas, M.A. Joyce, N.L. Barsby, R.F. Epand, R.M. Epand, S.A. Khramyshev, O.A. Valueva, V.A. Korshun, D.L.J. Tyrrell, and L.M. Schang. Proceedings of the National Academy of the Sciences USA, 2010. 107(40): p. 17339-17344. PMID[20823220].

[Pubmed]. HIV_1015-102810.

16. Exploration of piperidine-4-yl-aminopyrimidines as HIV-1 reverse transcriptase inhibitors. N-Phenyl derivatives with broad potency against resistant mutant viruses. Tang, G., D.J. Kertesz, M. Yang, X. Lin, Z. Wang, W. Li, Z. Qiu, J. Chen, J. Mei, L. Chen, T. Mirzadegan, S.F. Harris, A.G. Villasenor, J. Fretland, W.L. Fitch, J.Q. Hang, G. Heilek, and K. Klumpp. Bioorganic & Medicinal Chemistry Letters, 2010. 20(20): p. 6020-6023; PMID[20829038].

[Pubmed]. HIV_1015-102810.

17. Synthesis of N-Terminally Linked Protein and Peptide Dimers by Native Chemical Ligation. Xiao, J., B.S. Hamilton, and T.J. Tolbert. Bioconjugate Chemistry, 2010. [EPub Ahead of Print]; PMID[20973495].

[Pubmed]. HIV_1015-102810.

18. In vitro evaluation of marine-microorganism extracts for anti-viral activity. Yasuhara-Bell, J., Y.B. Yang, R. Barlow, H. Trapido-Rosenthal, and Y.A. Lu. Virology Journal, 2010. 7: p. 182. PMID[20691099].

[Pubmed]. HIV_1015-102810.

19. Small Molecule Inhibition of Human Immunodeficiency Virus Type 1 Infection by Virus Capsid Destabilization. Shi, J.Z., J; Shah, VB; Aiken, C; Whitby, K. The Journal of Virology., 2010. [Epub ahead of print]. PMID[20962083].

[Pubmed]. HIV_1015-102810.

ISI Web of Knowledge citations:

20. Inhibition of HIV-1 Release by Cell Permeable Peptides. Daniels, S.I., D.A. Davis, and R. Yarchoan. Journal of Acquired Immune Deficiency Syndromes, 2009. 51: p. 53-53. ISI[000281483700032].

[WOS]. HIV_1015-102810.

21. Dammarenolic acid, a secodammarane triterpenoid from Aglaia sp shows potent anti-retroviral activity in vitro. Esimone, C., G. Eck, C. Nworu, K. Uberla, and P. Proksch. Planta Medica, 2010. 76(12): p. 1309-1309. ISI[000282066500580].

[WOS]. HIV_1015-102810.

22. Potent Orally Bioavailable HIV-1 Fusion Inhibitors Alter Env Conformation and Expose Conserved Neutralization Epitopes. Finnegan, C., V. Dettmer, M. Bramah-Lawani, T. Nitz, P. Bullock, I. Burimski, M. Reddick, C. Matallana, C. Beaubien, D. Stanley, J. Pettitt, G. Allaway, and K. Salzwedel. Journal of Acquired Immune Deficiency Syndromes, 2009. 51: p. 138-138. ISI[000281483700114].

[WOS]. HIV_1015-102810.

23. Design, Synthesis, Anti-HIV and Cytotoxicity of Novel Heterocyclic Compounds. Selvam, P. Journal of Acquired Immune Deficiency Syndromes, 2009. 51: p. 126-126. ISI[000281483700102].

[WOS]. HIV_1015-102810.

24. Total Synthesis of (+/-)-Batzelladine K: A Biomimetic Approach. Ahmed, N., K.G. Brahmbhatt, I.P. Singh, and K.K. Bhutani. Synthesis-Stuttgart, 2010. (15): p. 2567-2570. ISI[000281783500013].

[WOS]. HIV_1015-102810.

25. Amino acid derivatives. Part 5. Synthesis and anti-HIV activity of new sebacoyl precursor derived thioureido-amino acid and phthalimide derivatives. Al-Masoudi, N.A., N. Al-Haidery, N.T. Faili, and C. Pannecouque. Arkivoc, 2010: (xi). p. 185-195. ISI[000282479700018].

[WOS]. HIV_1015-102810.

26. Synthesis of a PEG conjugated HIV Gp41 MPER fragment: a new Gp41 helix bundle mimic. D'Ursi, M., M. Grimaldi, A. Mastrogiacomo, G. Sabatino, F. Rizzolo, S. Giannecchini, and P. Rovero. 2010. 16(S1): p. 133-134. ISI[000281610800330].

[WOS]. HIV_1015-102810.

27. Carbosilane Dendrimers to Transfect Human Astrocytes with Small Interfering RNA Targeting Human Immunodeficiency Virus. Jimenez, J.L., M.I. Clemente, N.D. Weber, J. Sanchez, P. Ortega, F.J. de la Mata, R. Gomez, D. Garcia, L.A. Lopez-Fernandez, and M.A. Munoz-Fernandez. Biodrugs, 2010. 24(5): p. 331-343. ISI[000281937200006].

[WOS]. HIV_1015-102810.

28. Synthesis and anti-HIV-1 evaluation of phosphonates which mimic the 5 '-monophosphate of 4 '-branched 2 ',3 '-didehydro-2 ',3 '-dideoxy nucleosides. Kubota, Y., N. Ishizaki, K. Haraguchi, T. Hamasaki, M. Baba, and H. Tanaka. Bioorganic & Medicinal Chemistry, 2010. 18(20): p. 7186-7192.

[WOS]. HIV_1015-102810. ISI[000282369500004].

29. Acaconin, a chitinase-like antifungal protein with cytotoxic and anti-HIV-1 reverse transcriptase activities from Acacia confusa seeds. Lam, S.K. and T.B. Ng. Acta Biochimica Polonica, 2010. 57(3): p. 299-230. ISI[000282533000008].

[WOS]. HIV_1015-102810.

30. Modified Cyclic Peptides as Inhibitors of HIV-1 Integrase Activity. Northfield, E., S. Headey, M. Scanlon, P. Thompson, and D. Chalmers. Journal of Peptide Science, 2010. 16(S1): p. 130-130.

[WOS]. HIV_1015-102810.

31. Selection of Potent Non-Toxic Inhibitory Sequences from a Randomized HIV-1 Specific Lentiviral Short Hairpin RNA Library. Pongratz, C., B. Yazdanpanah, H. Kashkar, M.J. Lehmann, H.G. Krausslich, and M. Kronke. PLOS One, 2010. 5(10): e13172. ISI[000282676700003].

[WOS]. HIV_1015-102810.

32. Inhibition of HIV replication and integrase activity by isatin derivatives. Selvam, P. Journal of Acquired Immune Deficiency Syndromes, 2009. 51: p. 127-127. ISI[000281483700102].

[WOS]. HIV_1015-102810.

33. Anti-AIDS agents 84. Synthesis and anti-human immunodeficiency virus (HIV) activity of 2 '-monomethyl-4-methyl- and 1 '-thia-4-methyl-(3 ' R,4 ' R)-3 ',4 '-di-O-(S)-camphanoyl-(+)-cis-khellactone (DCK) analogs. Xu, S.Q., X. Yan, Y. Chen, P. Xia, K.D. Qian, D.L. Yu, Y. Xia, Z.Y. Yang, S.L. Morris-Natschke, and K.H. Lee. Bioorganic & Medicinal Chemistry, 2010. 18(20): p. 7203-7211. ISI[000282369500006].

[WOS]. HIV_1015-102810.

34. Organocatalytic asymmetric conjugate addition of cyclic 1,3-dicarbonyl compounds to beta,gamma-unsaturated alpha-ketoesters. Wang, J.J., J.H. Lao, Z.P. Hu, R.J. Lu, S.Z. Nie, Q.S. Du, and M. Yan. Arkivoc, 2010: p. 229-243. ISI[000282479700022].

[WOS]. HIV_1015-102810.

35. Inhibitory effects of heme arginate on HIV-1 Growth. Shankaran, P. and Z. Melkova. Cytokine, 2010. 52(1-2): p. 92-92. ISI[000282418400355].

[WOS]. HIV_1015-102810.